Clinical Trial Update: Efficacy and Safety of Heberprot-P® in Patients With Advanced Diabetic Foot Ulcer in Dasman Diabetes Institute.

View source ↗

Summary

This clinical trial update assesses the efficacy and safety of Heberprot-P in patients with advanced diabetic foot ulcers at Dasman Diabetes Institute. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Heberprot-P (recombinant human epidermal growth factor)

Snippet

Sponsor: Dasman Diabetes Institute | Conditions: Diabetic Foot | Status: COMPLETED